Selective factor VIII and V inactivation by iminodiacetate ion exchange resin through metal ion adsorption

British Journal of Haematology

Volumn 142, Issue 6, 2008, Pages 962-970

  Takeyama, Masahiro ^a   Nogami, Keiji ^a   Okuda, Masahiro ^b   Sakurai, Yoshihiko ^a   Matsumoto, Tomoko ^a   Tanaka, Ichiro ^a   Yoshioka, Akira ^a   Shima, Midori ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b SYSMEX CORPORATION   (Japan)

Author keywords

Factor V; Factor VIII; Iminodiacetate resin; Inactivation; Metal ion

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; CALCIUM; CARBOXYLIC ACID; COPPER; DIGLYCINE; ION EXCHANGE RESIN; MANGANESE; METAL ION; SULFONIC ACID DERIVATIVE; VON WILLEBRAND FACTOR;

ADSORPTION; ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; INHIBITION KINETICS; MOLECULAR DYNAMICS; PLASMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION;

BLOOD COAGULATION TESTS; CALCIUM; COPPER; FACTOR V; FACTOR VIII; HUMANS; IMINO ACIDS; IMMUNOSORBENT TECHNIQUES; ION EXCHANGE RESINS; MANGANESE;

EID: 50049113009     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07289.x     Document Type: Article

References (32)

1. Adams, T.E., Hockin, M.F., Mann, K.G. Everse, S.J. (2004) The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function. Proceedings of the National Academy of Sciences of the United States of America, 101, 8918 8923.
2. Bartley, W., Notton, B.M. Werkheiser, W.C. (1957) Determination of manganese in tissue extracts by means of formaldoxime. Biochemical Journal, 67, 291 295.
3. Biggs, R., Eveling, J. Richards, G. (1955) The assay of antihaemophilic globulin activity. British Journal of Haematology, 1, 20 34.
4. Connerty, H.V. Briggs, A.R. (1966) Determination of serum calcium by means of orthocresolphthalein complexone. American Journal of Clinical Pathology, 45, 290 296.
5. Fay, P.J. (1988) Reconstitution of human factor VIII from isolated subunits. Archives of Biochemistry and Biophysics, 262, 525 531.
6. Fay, P.J., Coumans, J.V. Walker, F.J. (1991) Von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. The Journal of Biological Chemistry, 266, 2172 2177.
7. Hardisty, R.M. MacPherson, J.C. (1962) A one-stage factor VIII (anti-haemophilic globulin) assay and its use on venous and capillary plasma. Thrombosis et Diathesis Haemorrhagica, 7, 215 229.
8. Kane, W.H. Davie, E.W. (1986) Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. Proceedings of the National Academy of Sciences of the United States of America, 83, 6800 6804.
9. Kane, W.H. Majerus, P.W. (1981) Purification and characterization of human coagulation. The Journal of Biological Chemistry, 256, 1002 1007.
10. Kaufman, R.J., Wasley, L.C., Davies, M.V., Wise, R.J., Israel, D.I. Dorner, A.J. (1989) Effect of von Willebrand factor coexpression on the synthesis and secretion of factor VIII in Chinese hamster ovary cells. Molecular and Cellular Biology, 9, 1233 1242.
11. Koedam, J.A., Hamer, R.J., Beeser-Visser, N.H., Bouma, B.N. Sixma, J.J. (1990) The effect of von Willebrand factor on activation of factor VIII by factor Xa. European Journal of Biochemistry, 189, 229 234.
12. Landers, J.W. Zak, B. (1958) Determination of serum copper and iron in a single small sample. American Journal of Clinical Pathology, 29, 590 592.
13. Lollar, P., Hill-Eubanks, D.C. Parker, C.G. (1988) Association of the factor VIII light chain with von Willebrand factor. The Journal of Biological Chemistry, 263, 10451 10455.
14. MacFarlane, D.E., Sttibe, J., Kirby, E.P., Zucker, M.B., Grant, R.A. MacPherson, J. (1975) A method for assaying von Willebrand factor (Ristocetin cofactor). Thrombosis et Diathesis Haemorrhagica, 34, 306 308.
15. Mann, K.G., Jenny, R.J. Krishnaswamy, S. (1988) Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Annual Review of Biochemistry, 57, 915 956.
16. Mann, K.G., Nesheim, M.E., Church, W.R., Haley, P. Krishnaswamy, S. (1990) Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood, 76, 1 16.
17. Nogami, K., Shima, M., Hosokawa, K., Suzuki, T., Koide, T., Saenko, E.L., Scandella, D., Shibata, M., Kamisue, S., Tanaka, I. Yoshioka, A. (1999) Role of factor VIII C2 domain in factor VIII binding to factor Xa. The Journal of Biological Chemistry, 274, 31000 31007.
18. Nogami, K., Shima, M., Nishiya, K., Hosokawa, K., Saenko, E.L., Sakurai, Y., Shibata, M., Suzuki, H., Tanaka, I. Yoshioka, A. (2002) A novel mechanism of factor VIII protection by von Willebrand factor from activated protein C-catalyzed inactivation. Blood, 99, 3993 3998.
19. Ofosu, F., Cassidy, K., Blajchman, M.A. Hirsh, J. (1980) Immunodepletion of human plasma factor VIII. Blood, 56, 604 607.
20. Pemberton, S., Lindley, P., Zaitsev, V., Card, G., Tuddenham, E.G. Kemball-Cook, G. (1997) A molecular model for the triplicated A domains of human factor VIII based on the crystal structure of human ceruloplasmin. Blood, 89, 2413 2421.
21. Saenko, E.L., Shima, M., Rajalakshmi, K.J. Scandella, D. (1994) A role for the C2 domain of factor VIII in binding to von Willebrand factor. The Journal of Biological Chemistry, 269, 11601 11605.
22. Saenko, E.L., Yakhyaev, A.V., Mikhailenko, I., Strickland, D.K. Sarafanov, A.G. (1999) Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. The Journal of Biological Chemistry, 274, 37685 37692.
23. Shima, M., Yoshioka, A., Nakajima, M., Nakai, H. Fukui, H. (1992) A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells. British Journal of Haematology, 81, 533 538.
24. Shima, M., Nakai, H., Scandella, D., Tanaka, I., Sawamoto, Y., Kamisue, S., Morichika, S., Murakami, T. Yoshioka, A. (1995) Common inhibitory effects of human anti-C2 domain inhibitor alloantibodies on factor VIII binding to von Willebrand factor. British Journal of Haematology, 91, 714 721.
25. Sorensen, K.W., Nicolaes, G.A., Villoutreix, B.O., Yamazaki, T., Tans, G., Rosing, J. Dahlbäck, B. (2004) Functional properties of recombinant factor V mutated in a potential calcium-binding site. Biochemistry, 43, 5803 5810.
26. Tagliavacca, L., Moon, N., Dunham, W.R. Kaufman, R.J. (1997) Identification and functional requirement of Cu(I) and its ligands within coagulation factor VIII. The Journal of Biological Chemistry, 272, 27428 27434.
27. Vehar, G.A., Keyt, B., Eaton, D., Rodriguez, H., O'Brien, D.P., Rotblat, F., Oppermann, H., Keck, R., Wood, W.I., Harkins, R.N., Tuddenham, E.G.D., Lawn, R.M. Capon, D.J. (1984) Structure of human factor VIII. Nature, 312, 337 342.
28. Wakabayashi, H., Koszelak, M.E., Mastri, M. Fay, P.J. (2001) Metal ion-independent association of factor VIII subunits and the roles of calcium and copper ions for cofactor activity and inter-subunit affinity. Biochemistry, 40, 10293 10300.
29. 2+ binding site required for cofactor activity. The Journal of Biological Chemistry, 279, 12677 12684.
30. 2+-binding site enhances cofactor interactions in factor Xase. Biochemistry, 44, 10298 10304.
31. Weiss, H.J., Sussman, I.I. Hoyer, L.W. (1977) Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. The Journal of Clinical Investigation, 60, 390 404.
32. Wolf, P. (1953) A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma. Journal of Clinical Pathology, 6, 34 38.